1. Hz and H. , 15 (d, 1H, 3 J 1'-2' = 4 Hz, H-1'), 5.45 (d, 1H, 3 J 1-2 = 3.5 Hz, pp.713-720

L. Composé, 95 mg, 856 µmol) est acylé par le chlorure de palmitoyle (52 µL, 2 éq.) selon le protocole d'acylation décrit (Protocole 5)

1. Hz and H. , 48 (d, 1H, 3 J 1-2 = 3.5 Hz, ), 5.77 (t, 1H, pp.5-15

L. Composé, mg, 3.31 µmol) est déprotégé selon le Protocole 8 pour donner quantitativement (2.5 mg, solide blanc

. Hz, 37 (d, 1H, 3 J 1'-2' = 3.5 Hz, H-1'), 5.48 (d, 1H, 3 J 1-2 = 4 Hz, p.5260

C. Dye, Global epidemiology of tuberculosis, The Lancet, vol.367, issue.9514, pp.938-940, 2006.
DOI : 10.1016/S0140-6736(06)68384-0

P. E. Fine and L. C. Rodrigues, Mycobacterial diseases, The Lancet, vol.335, issue.8696, pp.1016-1020, 1990.
DOI : 10.1016/0140-6736(90)91074-K

L. C. Rodrigues, V. K. Diwan, and J. G. Wheeler, Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-Analysis, International Journal of Epidemiology, vol.22, issue.6, pp.1154-1158, 1993.
DOI : 10.1093/ije/22.6.1154

. Bull, World Health Organ, pp.819-827, 1979.

T. Oettinger, M. Jorgensen, A. Ladefoged, K. Haslov, and P. Andersen, Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree, Tubercle and Lung Disease, vol.79, issue.4, pp.243-250, 1999.
DOI : 10.1054/tuld.1999.0206

J. Hess and S. H. Kaufmann, Live antigen carriers as tools for improved anti-tuberculosis vaccines, FEMS Immunology & Medical Microbiology, vol.23, issue.2, pp.165-173, 1999.
DOI : 10.1111/j.1574-695X.1999.tb01236.x

L. Brandt, J. F. Cunha, A. W. Olsen, B. Chilima, P. Hirsh et al., Failure of the Mycobacterium bovis BCG Vaccine: Some Species of Environmental Mycobacteria Block Multiplication of BCG and Induction of Protective Immunity to Tuberculosis, Infection and Immunity, vol.70, issue.2, pp.672-678, 2002.
DOI : 10.1128/IAI.70.2.672-678.2002

P. Andersen, Tuberculosis vaccines ??? an update, Nature Reviews Microbiology, vol.10, issue.7, pp.484-487, 2007.
DOI : 10.1038/nrmicro1703

P. Andersen and T. M. Doherty, Opinion: The success and failure of BCG ??? implications for a novel tuberculosis vaccine, Nature Reviews Microbiology, vol.171, issue.8, pp.656-662, 2005.
DOI : 10.1073/pnas.250480397

M. A. Horwitz and G. Harth, A New Vaccine against Tuberculosis Affords Greater Survival after Challenge than the Current Vaccine in the Guinea Pig Model of Pulmonary Tuberculosis, Infection and Immunity, vol.71, issue.4, pp.1672-1679, 2003.
DOI : 10.1128/IAI.71.4.1672-1679.2003

L. Grode, P. Seiler, S. Baumann, J. Hess, V. Brinkmann et al., Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin, Journal of Clinical Investigation, vol.115, issue.9, pp.2472-2479, 2005.
DOI : 10.1172/JCI24617

F. Winau, S. Weber, S. Sad, J. De-diego, S. L. Hoops et al., Apoptotic Vesicles Crossprime CD8 T Cells and Protect against Tuberculosis, Immunity, vol.24, issue.1, pp.105-117, 2006.
DOI : 10.1016/j.immuni.2005.12.001

H. Mcshane, A. A. Pathan, C. R. Sander, S. M. Keating, S. C. Gilbert et al., Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans, Nature Medicine, vol.169, issue.11, pp.1240-1244, 2004.
DOI : 10.1016/0882-4010(87)90077-5

J. Dietrich, C. Andersen, R. Rappuoli, T. M. Doherty, C. G. Jensen et al., Mucosal Administration of Ag85B-ESAT-6 Protects against Infection with Mycobacterium tuberculosis and Boosts Prior Bacillus Calmette-Guerin Immunity, The Journal of Immunology, vol.177, issue.9, pp.6353-6360, 2006.
DOI : 10.4049/jimmunol.177.9.6353

Y. A. Skeiky, M. R. Alderson, P. J. Ovendale, J. A. Guderian, L. Brandt et al., Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein, The Journal of Immunology, vol.172, issue.12, pp.7618-7628, 2004.
DOI : 10.4049/jimmunol.172.12.7618

E. M. Beckman, S. A. Porcelli, C. T. Morita, S. M. Behar, S. T. Furlong et al., Recognition of a lipid antigen by GDI-restricted ????+ T cells, Nature, vol.372, issue.6507, pp.691-694, 1994.
DOI : 10.1038/372691a0

P. A. Sieling, D. Chatterjee, S. A. Porcelli, T. I. Prigozy, R. J. Mazzaccaro et al., CD1-restricted T cell recognition of microbial lipoglycan antigens, Science, vol.269, issue.5221, pp.227-230, 1995.
DOI : 10.1126/science.7542404

C. C. Dascher, K. Hiromatsu, X. Xiong, C. Morehouse, G. Watts et al., Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis, International Immunology, vol.15, issue.8, pp.915-925, 2003.
DOI : 10.1093/intimm/dxg091

J. Cox and A. Coulter, Prospects for the Development of New Vaccine Adjuvants, BioDrugs, vol.12, issue.6, pp.439-453, 1999.
DOI : 10.2165/00063030-199912060-00004

B. M. Saunders and A. M. Cooper, Restraining mycobacteria: Role of granulomas in mycobacterial infections, Immunology and Cell Biology, vol.67, issue.4, pp.334-341, 2000.
DOI : 10.1046/j.1365-2567.1999.00663.x

N. M. Parrish, J. D. Dick, and W. R. Bishai, Mechanisms of latency in Mycobacterium tuberculosis, Trends in Microbiology, vol.6, issue.3, pp.107-112, 1998.
DOI : 10.1016/S0966-842X(98)01216-5

U. E. Schaible, H. L. Collins, and S. H. Kaufmann, Confrontation between Intracellular Bacteria and the Immune System, Adv. Immunol, vol.71, pp.267-377, 1999.
DOI : 10.1016/S0065-2776(08)60405-8

S. H. Kaufmann, How can immunology contribute to the control of tuberculosis?, Nature Reviews Immunology, vol.97, issue.1, pp.20-30, 2001.
DOI : 10.1038/35095558

S. Porcelli, C. T. Morita, and M. B. Brenner, CDlb restricts the response of human CD4???8???T lymphocytes to a microbial antigen, Nature, vol.360, issue.6404, pp.593-597, 1992.
DOI : 10.1038/360593a0

S. A. Porcelli and R. L. Modlin, THE CD1 SYSTEM: Antigen-Presenting Molecules for T Cell Recognition of Lipids and Glycolipids, Annual Review of Immunology, vol.17, issue.1, pp.297-329, 1999.
DOI : 10.1146/annurev.immunol.17.1.297

S. A. Porcelli, The CD1 Family: A Third Lineage of Antigen-Presenting Molecules, Adv. Immunol, vol.59, pp.1-98, 1995.
DOI : 10.1016/S0065-2776(08)60629-X

U. E. Schaible, K. Hagens, K. Fischer, H. L. Collins, and S. H. Kaufmann, Intersection of Group I CD1 Molecules and Mycobacteria in Different Intracellular Compartments of Dendritic Cells, The Journal of Immunology, vol.164, issue.9, pp.4843-4852, 2000.
DOI : 10.4049/jimmunol.164.9.4843

U. E. Schaible and S. H. Kaufmann, CD1 and CD1-restricted T cells in infections with intracellular bacteria, Trends in Microbiology, vol.8, issue.9, pp.419-425, 2000.
DOI : 10.1016/S0966-842X(00)01829-1

T. Ulrichs, D. B. Moody, E. Grant, S. H. Kaufmann, and S. A. Porcelli, T-Cell Responses to CD1-Presented Lipid Antigens in Humans with Mycobacterium tuberculosis Infection, Infection and Immunity, vol.71, issue.6, pp.3076-3087, 2003.
DOI : 10.1128/IAI.71.6.3076-3087.2003

T. Kawashima, Y. Norose, Y. Watanabe, Y. Enomoto, H. Narazaki et al., Cutting Edge: Major CD8 T Cell Response to Live Bacillus Calmette-Guerin Is Mediated by CD1 Molecules, The Journal of Immunology, vol.170, issue.11, pp.5345-5348, 2003.
DOI : 10.4049/jimmunol.170.11.5345

A. Lalvani, CD8 Cytotoxic T Cells and the Development of New Tuberculosis Vaccines, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.6, pp.789-790, 2002.
DOI : 10.1164/rccm.2206002

F. Calabi, J. M. Jarvis, L. Martin, and C. Milstein, Two classes of CD1 genes, European Journal of Immunology, vol.12, issue.2, pp.285-292, 1989.
DOI : 10.1002/eji.1830190211

C. Angenieux, J. Salamero, D. Fricker, J. P. Cazenave, B. Goud et al., Characterization of CD1e, a Third Type of CD1 Molecule Expressed in Dendritic Cells, Journal of Biological Chemistry, vol.275, issue.48, pp.37757-37764, 2000.
DOI : 10.1074/jbc.M007082200

M. Brigl and M. B. Brenner, CD1: Antigen Presentation and T Cell Function, Annual Review of Immunology, vol.22, issue.1, pp.817-890, 2004.
DOI : 10.1146/annurev.immunol.22.012703.104608

D. B. Moody, D. M. Zajonc, and I. A. Wilson, Anatomy of CD1???lipid antigen complexes, Nature Reviews Immunology, vol.11, issue.5, pp.387-399, 2005.
DOI : 10.1016/0022-2836(87)90124-0

T. Batuwangala, D. Shepherd, S. D. Gadola, K. J. Gibson, N. R. Zaccai et al., The Crystal Structure of Human CD1b with a Bound Bacterial Glycolipid, The Journal of Immunology, vol.172, issue.4, pp.2382-2388, 2004.
DOI : 10.4049/jimmunol.172.4.2382

D. M. Zajonc, M. A. Elsliger, L. Teyton, and I. A. Wilson, Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 ??, Nature Immunology, vol.4, issue.8, pp.808-815, 2003.
DOI : 10.1038/ni948

L. F. Garcia-alles, K. Versluis, L. Maveyraud, A. T. Vallina, S. Sansano et al., Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b, The EMBO Journal, vol.8, issue.15, pp.3684-3692, 2006.
DOI : 10.1126/science.1092009

M. Koch, V. S. Stronge, D. Shepherd, S. D. Gadola, B. Mathew et al., The crystal structure of human CD1d with and without ??-galactosylceramide, Nature Immunology, vol.328, issue.8, pp.819-826, 2005.
DOI : 10.1038/nsb0497-269

N. A. Borg, K. S. Wun, L. Kjer-nielsen, M. C. Wilce, D. G. Pellicci et al., CD1d???lipid-antigen recognition by the semi-invariant NKT T-cell receptor, Nature, vol.18, issue.7149, pp.44-49, 2007.
DOI : 10.1038/nature05907

S. A. Porcelli and M. B. Brenner, Antigen presentation: Mixing oil and water, Current Biology, vol.7, issue.8, pp.508-511, 1997.
DOI : 10.1016/S0960-9822(06)00250-8

E. P. Grant, E. M. Beckman, S. M. Behar, M. Degano, D. Frederique et al., Fine Specificity of TCR Complementarity-Determining Region Residues and Lipid Antigen Hydrophilic Moieties in the Recognition of a CD1-Lipid Complex, The Journal of Immunology, vol.168, issue.8, pp.3933-3940, 2002.
DOI : 10.4049/jimmunol.168.8.3933

A. Melian, G. F. Watts, A. Shamshiev, G. De-libero, A. Clatworthy et al., Molecular Recognition of Human CD1b Antigen Complexes: Evidence for a Common Pattern of Interaction with ???? TCRs, The Journal of Immunology, vol.165, issue.8, pp.4494-4504, 2000.
DOI : 10.4049/jimmunol.165.8.4494

D. B. Moody, D. C. Young, T. Y. Cheng, J. P. Rosat, C. Roura-mir et al., T Cell Activation by Lipopeptide Antigens, Science, vol.303, issue.5657, pp.527-531, 2004.
DOI : 10.1126/science.1089353

I. Van-rhijn, D. M. Zajonc, I. A. Wilson, and D. B. Moody, T-cell activation by lipopeptide antigens, Current Opinion in Immunology, vol.17, issue.3, pp.222-229, 2005.
DOI : 10.1016/j.coi.2005.04.006

J. Rauch, J. Gumperz, C. Robinson, M. Skold, C. Roy et al., Structural Features of the Acyl Chain Determine Self-phospholipid Antigen Recognition by a CD1d-restricted Invariant NKT (iNKT) Cell, Journal of Biological Chemistry, vol.278, issue.48, pp.47508-47515, 2003.
DOI : 10.1074/jbc.M308089200

D. B. Moody, T. Ulrichs, W. Muhlecker, D. C. Young, S. S. Gurcha et al., CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection, Nature, vol.404, issue.6780, pp.884-888, 2000.
DOI : 10.1038/35009119

I. Matsunaga, A. Bhatt, D. C. Young, T. Y. Cheng, S. J. Eyles et al., Produces a Novel Polyketide Presented by CD1c to T Cells, The Journal of Experimental Medicine, vol.162, issue.12, pp.1559-1569, 2004.
DOI : 10.1016/S0092-8674(00)80412-2

K. Miyamoto, S. Miyake, and T. Yamamura, A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells, Nature, vol.5, issue.6855, pp.531-534, 2001.
DOI : 10.1038/35097097

D. Y. Wu, N. H. Segal, S. Sidobre, M. Kronenberg, and P. B. Chapman, Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells, The Journal of Experimental Medicine, vol.157, issue.1, pp.173-181, 2003.
DOI : 10.1084/jem.20021616

A. D. De-silva, J. J. Park, N. Matsuki, A. K. Stanic, R. R. Brutkiewicz et al., Lipid Protein Interactions: The Assembly of CD1d1 with Cellular Phospholipids Occurs in the Endoplasmic Reticulum, The Journal of Immunology, vol.168, issue.2, pp.723-733, 2002.
DOI : 10.4049/jimmunol.168.2.723

M. Sugita, M. Cernadas, and M. B. Brenner, New insights into pathways for CD1-mediated antigen presentation, Current Opinion in Immunology, vol.16, issue.1, pp.90-95, 2004.
DOI : 10.1016/j.coi.2003.11.014

D. B. Moody and S. A. Porcelli, Intracellular pathways of CD1 antigen presentation, Nature Reviews Immunology, vol.3, issue.1, pp.11-22, 2003.
DOI : 10.1038/nri979

S. Mukherjee and F. R. Maxfield, Role of Membrane Organization and Membrane Domains in Endocytic Lipid Trafficking, Traffic, vol.1, issue.Suppl., pp.203-211, 2000.
DOI : 10.1034/j.1600-0854.2000.010302.x

S. Mukherjee, T. T. Soe, and F. R. Maxfield, Endocytic Sorting of Lipid Analogues Differing Solely in the Chemistry of Their Hydrophobic Tails, The Journal of Cell Biology, vol.822, issue.6, pp.1271-1284, 1999.
DOI : 10.1016/0092-8674(84)90414-8

M. Sugita, E. P. Grant, E. Van-donselaar, V. W. Hsu, R. A. Rogers et al., Separate Pathways for Antigen Presentation by CD1 Molecules, Immunity, vol.11, issue.6, pp.743-752, 1999.
DOI : 10.1016/S1074-7613(00)80148-X

D. M. Zajonc, C. Cantu, J. Mattner, D. Zhou, P. B. Savage et al., Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor, Nature Immunology, vol.50, issue.8, pp.810-818, 2005.
DOI : 10.1093/intimm/13.7.853

T. I. Prigozy, O. Naidenko, P. Qasba, D. Elewaut, L. Brossay et al., Glycolipid Antigen Processing for Presentation by CD1d Molecules, Science, vol.291, issue.5504, pp.664-667, 2001.
DOI : 10.1126/science.291.5504.664

D. B. Moody, M. R. Guy, E. Grant, T. Y. Cheng, M. B. Brenner et al., Cd1b-Mediated T Cell Recognition of a Glycolipid Antigen Generated from Mycobacterial Lipid and Host Carbohydrate during Infection, The Journal of Experimental Medicine, vol.18, issue.7, pp.965-976, 2000.
DOI : 10.1016/S0092-8674(00)80412-2

M. Morita, K. Motoki, K. Akimoto, T. Natori, T. Sakai et al., Structure-Activity Relationship of .alpha.-Galactosylceramides against B16-Bearing Mice, Journal of Medicinal Chemistry, vol.38, issue.12, pp.2176-2187, 1995.
DOI : 10.1021/jm00012a018

R. M. Ndonye, D. P. Izmirian, M. F. Dunn, K. O. Yu, S. A. Porcelli et al., Synthesis and Evaluation of Sphinganine Analogues of KRN7000 and OCH, The Journal of Organic Chemistry, vol.70, issue.25, pp.10260-10270, 2005.
DOI : 10.1021/jo051147h

R. D. Goff, Y. Gao, J. Mattner, D. Zhou, N. Yin et al., Effects of Lipid Chain Lengths in ??-Galactosylceramides on Cytokine Release by Natural Killer T Cells, Journal of the American Chemical Society, vol.126, issue.42, pp.13602-13603, 2004.
DOI : 10.1021/ja045385q

S. D. Gadola, M. Koch, J. Marles-wright, N. M. Lissin, D. Shepherd et al., Structure and binding kinetics of three different human CD1d?????-galactosylceramide???specific T cell receptors, The Journal of Experimental Medicine, vol.156, issue.3, pp.699-710, 2006.
DOI : 10.4049/jimmunol.172.4.2382

L. Kjer-nielsen, N. A. Borg, D. G. Pellicci, T. Beddoe, L. Kostenko et al., A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition, The Journal of Experimental Medicine, vol.161, issue.3, pp.661-673, 2006.
DOI : 10.1084/jem.192.5.741

M. B. Goren, O. Brokl, B. C. Das, and E. Lederer, Sulfolipid I of Mycobacterium tuberculosis, strain H37RV. Nature of the acyl substituents, Biochemistry, vol.10, issue.1, pp.72-81, 1971.
DOI : 10.1021/bi00777a012

H. H. Baer and X. Wu, Synthesis of ??,??-trehalose 2,3- and 2,3???-diesters with palmitic and stearic acid: potential immunoreactants for the serodiagnosis of tuberculosis, Carbohydrate Research, vol.238, pp.215-230, 1993.
DOI : 10.1016/0008-6215(93)87014-J

A. Liav and M. B. Goren, Sulfatides of Mycobacterium tuberculosis. Synthesis of the core ??,??-trehalose 2-sulfate, Carbohydrate Research, vol.127, issue.2, pp.211-216, 1984.
DOI : 10.1016/0008-6215(84)85355-0

H. H. Baer and B. Radatus, Preparation of some partially protected, ??,??-trehalose-type disaccharides having the d-altro configuration, Carbohydrate Research, vol.128, issue.1, pp.165-174, 1984.
DOI : 10.1016/0008-6215(84)85095-8

J. Gelas and D. Horton, Partial acetylation of methyl ??-D-glucopyranoside with 1-acetylimidazole, Carbohydrate Research, vol.64, pp.323-326, 1978.
DOI : 10.1016/S0008-6215(00)83719-2

M. B. Goren, Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv I. Purification and properties, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.210, issue.1, pp.116-126, 1970.
DOI : 10.1016/0005-2760(70)90067-6

D. E. Minnikin, L. Kremer, L. G. Dover, and G. S. Besra, The Methyl-Branched Fortifications of Mycobacterium tuberculosis, Chemistry & Biology, vol.9, issue.5, pp.545-553, 2002.
DOI : 10.1016/S1074-5521(02)00142-4

M. B. Goren, Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv II. Structural studies, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.210, issue.1, pp.127-138, 1970.
DOI : 10.1016/0005-2760(70)90068-8

L. Katz, Manipulation of Modular Polyketide Synthases, Chemical Reviews, vol.97, issue.7, pp.2557-2576, 1997.
DOI : 10.1021/cr960025+

C. Khosla, Harnessing the Biosynthetic Potential of Modular Polyketide Synthases, Chemical Reviews, vol.97, issue.7, pp.2577-2590, 1997.
DOI : 10.1021/cr960027u

G. S. Besra, D. E. Minnikin, P. R. Wheeler, and C. Ratledge, Synthesis of methyl (Z)-tetracos-5-enoate and both enantiomers of ethyl (E)-6-methyltetracos-4-enoate: possible intermediates in the biosynthesis of mycolic acids in mycobacteria, Chemistry and Physics of Lipids, vol.66, issue.1-2, pp.23-34, 1993.
DOI : 10.1016/0009-3084(93)90027-Z

D. A. Evans, R. L. Dow, T. L. Shih, J. M. Takacs, and R. Zahler, Total synthesis of the polyether antibiotic ionomycin, Journal of the American Chemical Society, vol.112, issue.13, pp.5290-5313, 1990.
DOI : 10.1021/ja00169a042

D. A. Evans, J. V. Nelson, E. Vogel, and T. R. Taber, Stereoselective aldol condensations via boron enolates, Journal of the American Chemical Society, vol.103, issue.11, pp.3099-3111, 1981.
DOI : 10.1021/ja00401a031

D. A. Evans, D. L. Rieger, M. T. Bilodeau, and F. Urpi, Stereoselective aldol reactions of chlorotitanium enolates. An efficient method for the assemblage of polypropionate-related synthons, Journal of the American Chemical Society, vol.113, issue.3, pp.1047-1049, 1991.
DOI : 10.1021/ja00003a051

D. A. Evans, J. S. Clark, R. Metternich, V. J. Novack, and G. S. Sheppard, Diastereoselective aldol reactions using .beta.-keto imide derived enolates. A versatile approach to the assemblage of polypropionate systems, Journal of the American Chemical Society, vol.112, issue.2, pp.866-868, 1990.
DOI : 10.1021/ja00158a056

D. A. Evans, M. D. Ennis, and D. J. Mathre, Asymmetric alkylation reactions of chiral imide enolates. A practical approach to the enantioselective synthesis of .alpha.-substituted carboxylic acid derivatives, Journal of the American Chemical Society, vol.104, issue.6, pp.1737-1739, 1982.
DOI : 10.1021/ja00370a050

A. G. Myers, B. H. Yang, H. Chen, L. Mckinstry, D. J. Kopecky et al., Pseudoephedrine as a Practical Chiral Auxiliary for the Synthesis of Highly Enantiomerically Enriched Carboxylic Acids, Alcohols, Aldehydes, and Ketones, Journal of the American Chemical Society, vol.119, issue.28, pp.6496-6511, 1997.
DOI : 10.1021/ja970402f

M. O. Duffey, A. Letiran, and J. P. Morken, Enantioselective Total Synthesis of Borrelidin, Journal of the American Chemical Society, vol.125, issue.6, pp.1458-1459, 2003.
DOI : 10.1021/ja028941u

A. Job, C. F. Janeck, W. Bettray, R. Peters, and D. Enders, The SAMP-/RAMP-hydrazone methodology in asymmetric synthesis, Tetrahedron, vol.58, issue.12, pp.2253-2329, 2002.
DOI : 10.1016/S0040-4020(02)00080-7

C. Spino, C. Beaulieu, and J. Lafreniere, 2??? Displacement of Cuprates on Chiral Carbonates:?? An Alternative to the Alkylation of Chiral Enolates, The Journal of Organic Chemistry, vol.65, issue.21, pp.7091-7097, 2000.
DOI : 10.1021/jo000810t

C. Spino and M. Allan, An iterative approach to three fragments of ionomycin, Canadian Journal of Chemistry, vol.82, issue.2, pp.177-184, 2004.
DOI : 10.1139/v03-182

D. R. Williams, A. L. Nold, and R. J. Mullins, -1,3-Dimethyl Arrays:?? Synthesis and Structure Elucidation of Capensifuranone, The Journal of Organic Chemistry, vol.69, issue.16, pp.5374-5382, 2004.
DOI : 10.1021/jo049567e
URL : https://hal.archives-ouvertes.fr/hal-00409061

R. Desmazery, M. Pullez, F. Lopez, S. R. Harutyunyan, A. J. Minnaard et al., An Iterative Catalytic Route to Enantiopure Deoxypropionate Subunits:?? Asymmetric Conjugate Addition of Grignard Reagents to ??,??-Unsaturated Thioesters, Journal of the American Chemical Society, vol.127, issue.28, pp.9966-9967, 2005.
DOI : 10.1021/ja053020f

R. U. Lemieux, D. R. Bundle, and D. A. Baker, Properties of a synthetic antigen related to the human blood-group Lewis a, Journal of the American Chemical Society, vol.97, issue.14, pp.4076-4083, 1975.
DOI : 10.1021/ja00847a035

L. Alcaraz, G. Macdonald, J. Ragot, N. J. Lewis, and R. J. Taylor, Synthetic approaches to the Manumycin A, B and C antibiotics: The first total synthesis of (+)-Manumycin A, Tetrahedron, vol.55, issue.12, pp.3707-3716, 1999.
DOI : 10.1016/S0040-4020(98)00879-5

A. De-jong, E. C. Arce, T. Cheng, R. P. Van-summeren, B. L. Feringa et al., CD1c Presentation of Synthetic Glycolipid Antigens with Foreign Alkyl Branching Motifs, Chemistry & Biology, vol.14, issue.11, pp.1232-1242, 2007.
DOI : 10.1016/j.chembiol.2007.09.010